Diffusion Kurtosis Imaging for Basal Ganglia Diagnosis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic methods for Parkinson's Disease and related neurodegenerative disorders lack accuracy in differentiating between patients and control subjects, as conventional MRI techniques fail to precisely capture the structural complexity changes in the basal ganglia.

Innovation Solution

Diffusion kurtosis imaging (DKI) is employed to analyze the structural complexity in the basal ganglia, involving image acquisition, calculation of diffusion kurtosis, selection of regions of interest, and comparison of DK data between patients and control subjects, providing improved diagnostic sensitivity and specificity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional diffusion tensor imaging is used, then the measurement of directional dependence of diffusion is achieved, but the accuracy in differentiating Parkinson's Disease patients from control subjects remains insufficient

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidimaging technique complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent transitions from conventional diffusion tensor imaging parameters (FA, MD) to diffusion kurtosis imaging parameters (MK, AK, RK) to capture non-Gaussian diffusion behavior. This parameter change enables more accurate characterization of tissue microstructure in the basal ganglia, improving diagnostic accuracy for Parkinson's Disease while maintaining a comparable imaging methodology

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent adds the dimension of kurtosis analysis to the traditional diffusion tensor framework. By incorporating mean kurtosis, axial kurtosis, and radial kurtosis parameters, the method provides an additional dimension of information about tissue microstructural complexity, enabling better differentiation between PD patients and controls

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If conventional MRI techniques are used, then imaging of the substantia nigra is performed, but the ability to precisely capture structural complexity changes is insufficient

Engineering Contradiction:
Improvestructural complexity measurementVSAvoiddetection difficulty
Core Design Contradiction:
Measurement precisionVSDifficulty of detecting and measuring

Solution Approach 1:

The patent introduces diffusion kurtosis parameters (MK, AK, RK) that specifically quantify non-Gaussian diffusion behavior, providing a more sensitive measure of structural complexity changes in the basal ganglia compared to conventional MRI parameters. This enables precise detection of microstructural alterations associated with Parkinson's Disease

Inventive Principle:
Principle #35Parameter changes

3Reliability

If diffusion tensor imaging is used, then directional dependence of diffusion is measured, but the assumption of free and unrestricted medium is violated in heterogeneous living tissues

Engineering Contradiction:
Improvemodel accuracyVSAvoiddiffusion model complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent moves from the diffusion tensor model (which assumes Gaussian diffusion) to the diffusion kurtosis model that explicitly accounts for non-Gaussian diffusion behavior in heterogeneous tissues. This parameter change improves model reliability by removing the unrealistic assumption of free and unrestricted diffusion, better capturing the complex microenvironment of living tissues

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

DKI significantly enhances the MR-based diagnosis of Parkinson's Disease and related disorders by accurately differentiating patients from control subjects, offering superior diagnostic performance compared to conventional diffusion tensor imaging.

Implementation Method 1

water diffusion in living tissue is hindered by interactions with other molecules and cell membranes. Therefore, water in biologic structures often displays non-Gaussian diffusion behavior

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 2

MR diffusion kurtosis imaging has been recently proposed as a means of quantifying non-Gaussian water diffusion

Methodology Applied
Scientific EffectMagnetic Resonance:

Data Source

PatentUS9031292B2Method for the diagnosis of neurodegenerative disorder by using diffusion kurtosis imaging
Publication Date: 2015.05.12 CHANG GUNG UNIVERSITY
  • US9031292B2 patent drawing
  • US9031292B2 patent drawing
  • US9031292B2 patent drawing

AI summary

The invention relates to the use of diffusion kurtosis imaging (DKI) in the diagnosis of Parkinson Disease related neurodegenerative disorders, including (but not limited to) Parkinson's disease (PD) and Parkinson plus syndromes.